PHARM LYSE Trademark
Trademark Overview
On Monday, March 24, 1997, a trademark application was filed for PHARM LYSE with the United States Patent and Trademark Office. The USPTO has given the PHARM LYSE trademark a serial number of 75262656. The federal status of this trademark filing is ABANDONED - EXPRESS as of Tuesday, December 2, 1997. This trademark is owned by PHARMINGEN. The PHARM LYSE trademark is filed in the Chemical Products category with the following description:
products relating to the isolation of blood cell constituents
General Information
Serial Number | 75262656 |
Word Mark | PHARM LYSE |
Filing Date | Monday, March 24, 1997 |
Status | 601 - ABANDONED - EXPRESS |
Status Date | Tuesday, December 2, 1997 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 1000 - Typeset: Word(s) / letter(s) / number(s) |
Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
Goods and Services | products relating to the isolation of blood cell constituents |
Classification Information
International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
US Class Codes | 001, 005, 006, 010, 026, 046 |
Class Status Code | 8 - Abandoned |
Class Status Date | Wednesday, August 4, 1999 |
Primary Code | 001 |
First Use Anywhere Date | Monday, April 22, 1996 |
First Use In Commerce Date | Monday, April 22, 1996 |
Trademark Owner History
Party Name | PHARMINGEN |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | SAN DIEGO, CA 921211111 |
Trademark Events
Event Date | Event Description |
Tuesday, December 2, 1997 | ABANDONMENT - EXPRESS MAILED |
Tuesday, September 30, 1997 | NON-FINAL ACTION MAILED |
Saturday, September 27, 1997 | ASSIGNED TO EXAMINER |